Internal Server Error

Epocrates - About the company

Epocrates is an acquired company based in San Mateo (United States), founded in 1998 by Richard Fiedotin. It operates as a Clinical decision support tool providing continually updated medical content for clinicians. Epocrates has raised $35M in funding, with last known valuation of $*****. The company has 137 active competitors, including 24 funded and 17 that have exited. Its top competitors include companies like Memed, Eon and ProVation Medical.

Company Details

Clinical decision support tool providing continually updated medical content for clinicians. It offers essential, researched, and updated clinical content to healthcare professionals. The platform delivers in-depth clinical information, enabling providers to prescribe safely and efficiently at the point of care. It is a software solution designed to be a reliable resource for medical professionals, offering features that support informed decision-making. The company focuses on providing accurate and condensed data, ensuring clinicians have access to trusted information. It is a B2B tech company offering a valuable tool for modern medical practice, enhancing patient care through accessible and reliable medical knowledge.
Social
XFacebook
Key Metrics
Founded Year
1998
Location
San Mateo, United States
Stage
Acquired
Total Funding
$35M in 2 rounds
Latest Funding Round
Last Known Valuation
$***** as on Jan 07, 2013
Ranked
Annual Revenue
$100M - $500M as on Dec 31, 2012
Employee Count
10 - 49 as on Mar 01, 2026
Similar Companies
Exit Details
Acquired by athenahealth (Jan 07, 2013)

Epocrates's acquisition details

Epocrates got acquired by athenahealth on Jan 07, 2013 at an acquisition amount of $*****.
Click here to take a look at Epocrates's acquisition in detail
Sign up to download Epocrates' company profile

Epocrates's funding and investors

Epocrates has raised a total funding of $35M over 2 rounds. Its first funding round was on Aug 20, 2000. Its latest funding round was a Series C round on Aug 19, 2002 for $*****. 4 investors participated in its latest round. Epocrates has 10 institutional investors.

Here is the list of recent funding rounds of Epocrates:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Aug 19, 2002
3780177
Series C
2783629
1449153
5034693
1635688
Aug 20, 2000
5514971
Series B
1849043
8350428
6114422
lockAccess funding benchmarks and valuations. Sign up today!

Epocrates' founders and board of directors

Founder? Claim Profile
The founders of Epocrates is Richard Fiedotin.
Here are the details of Epocrates' key team members:

Epocrates' employee count trend

Epocrates has 10 - 49 employees as of Mar 26. Here is Epocrates's employee count trend over the years:
Employee count trend for Epocrates
lockUncover Epocrates' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Epocrates's Competitors and alternates

Top competitors of Epocrates include Memed, Eon and ProVation Medical. Here is the list of Top 10 competitors of Epocrates, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Memed
Memed
2012, Sao Paulo (Brazil), Series C
Application with curated drug information used by physicians
$97.9M
57/100
2nd
Logo for Eon
Eon
2014, Denver (United States), Series B
Provider of patient management software
$22M
56/100
3rd
Logo for Epocrates
Epocrates
1998, San Mateo (United States), Acquired
Clinical decision support tool providing continually updated medical content for clinicians
$35M
52/100
4th
Logo for ProVation Medical
ProVation Medical
1994, Minneapolis (United States), Acquired
Clinical documentation and workflow automation solutions improving healthcare quality
$14.5M
53/100
5th
Logo for Yuimedi
Yuimedi
2020, Minato City (Japan), Seed
Provider of medical data analysis platform to enhance the healthcare system
$8.34M
52/100
6th
Logo for MMIT Network
MMIT Network
1994, Yardley (United States), Acquired
Provider of data, analytics, and software for pharmaceutical and healthcare sectors
$27.4M
46/100
7th
Logo for Stabl
Stabl
2021, Dallas (United States), Acquired
Digital patient treatment planning tool for healthcare professionals
-
44/100
8th
Logo for AgileMD
AgileMD
2011, San Francisco (United States), Seed
AI-powered clinical decision support for better healthcare outcomes and efficiency
$2M
44/100
9th
Logo for Medicomp
Medicomp
1978, Chantilly (United States), Funding Raised
Diagnostically connecting data to improve patient outcomes and empower healthcare providers
-
-
43/100
10th
Logo for Decisio Health
Decisio Health
2013, Houston (United States), Acquired
Clinical intelligence platform transforming data into actionable insights for better healthcare
$35.4M
42/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Epocrates's competitors? Click here to see the top ones

Epocrates's Investments and acquisitions

Epocrates has made no investments or acquisitions yet.

Reports related to Epocrates

Here is the latest report on Epocrates's sector:

News related to Epocrates

lockFilter this list
Media has covered Epocrates for 1 event in last 1 year, It was about partnerships.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Epocrates

Explore our recently published companies
  • Spolyn - Sonipat based, 2025 founded, Unfunded company
  • DARCA - Lithuania based, 2024 founded, Unfunded company
  • CSJ Plasmasys - Kolkata based, 2022 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford